Key statistics
On Friday, Biohaven Ltd (ZH6:BER) closed at 39.60, -28.20% below its 52-week high of 55.15, set on Mar 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 39.80 |
---|---|
High | 40.40 |
Low | 39.40 |
Bid | 38.00 |
Offer | 40.40 |
Previous close | 39.80 |
Average volume | 0.00 |
---|---|
Shares outstanding | 101.12m |
Free float | 85.42m |
P/E (TTM) | -- |
Market cap | 3.89bn USD |
EPS (TTM) | -9.35 USD |
Data delayed at least 15 minutes, as of Feb 14 2025 20:48 GMT.
More ▼
Press releases
- Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New Drug Application for the Treatment of Spinocerebellar Ataxia
- Biohaven Highlights Portfolio Progress, Innovation, and Anticipated Milestones at the 43rd Annual J.P. Morgan Healthcare Conference; Reports Positive Degrader Data with Rapid, Deep, and Selective Lowering of Galactose-Deficient IgA1 with Next Generation Potential Therapy for IgA Nephropathy
- Biohaven to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- Biohaven Reports Positive Phase 1 Degrader Data, Achieving Deep Targeted IgG Reductions in the Lowest Subcutaneous Dose Tested; Announces NDA Submission for Troriluzole in SCA and Provides Other Key Program Updates
- Biohaven Presents New Data with BHV-7000 Once-Daily Extended-Release Formulation Demonstrating Excellent Safety Profile and Nonclinical Data Updates at American Epilepsy Society 2024 Annual Meeting
- Biohaven Provides Update on Taldefgrobep Alfa Development Program for Spinal Muscular Atrophy and Obesity
More ▼